Proprio was founded by Gabriel Jones, Samuel Browd, Joshua Smith, James Youngquist in 2016.

Who are Proprio's investors?

Proprio's investors include Bold Capital Partners, Cota Capital, DCVC (Data Collective), Bird B. AG, HTC, Presence Capital, BOLD Longevity, Recode Ventures and 3 more.

How much funding has Proprio raised?

Proprio has disclosed $43M raised across 1 of its 4 known rounds.

Where is Proprio headquartered?

Proprio is headquartered in Seattle, US.

Proprio

Seattle, US · Founded 2016 · 2,929 employees on LinkedIn · 11 known investors

Find your way into Proprio

294 people in our graph share verified history with the Proprio team — schools, employers, funds. One of them is your warm intro.

Gabrielle Hamillunlockedknows Samuel Browd · together at Seattle Seahawks (overlapped)

×3knows the team · via Proprio

×2knows the team · via Seattle Children's

×3knows the team · via UW Foster School of Business

×3knows the team · via Seattle Seahawks

Proprio develops Paradigm, an implant-agnostic surgical platform that provides intraoperative guidance and structured surgical data without requiring 3D imaging or mobile CT. The system is built for hospitals and health systems to increase surgical capacity, standardize performance, and support clinical training through an AI foundation model trained on data from hundreds of surgeons.

AI & Machine Learning Healthtech Medical Devices

Founders & leadership

Proprio was founded in 2016 by Gabriel Jones, Samuel Browd, Joshua Smith, and James Youngquist.

Gabriel Jones Co-founder & CEOHe brings over two decades of experience in technology and healthcare product development, business development, and strategy, with background raising capital and securing patents across medical device ventures.

Samuel Browd Co-founderSamuel Browd is co-founder of Proprio, which develops an implant-agnostic surgical platform providing intraoperative guidance and structured surgical data. He works at the intersection of technology and healthcare, with expertise spanning AI, computer vision, and related domains applied to neurological care.

Joshua SmithCo-founder

James YoungquistCo-founder

Investors · 11

Bold Capital Partners✓ confirmed by ProprioSanta Monica

How we know: Bold Capital Partners's portfolio page · the company's own site · a partner's Signal profile · press coverage · Not right? Tell us

Cota Capital✓ confirmed by ProprioSan Francisco

How we know: the company's own site · press coverage · Not right? Tell us

DCVC (Data Collective)✓ confirmed by ProprioPalo Alto · $5M – $25M

How we know: the company's own site · a partner's Signal profile · funding news · press coverage · the VCSheet dataset · Not right? Tell us

Bird B. AG✓ confirmed by ProprioSchaffhausen

How we know: the company's own site · Not right? Tell us

HTC✓ confirmed by ProprioTaoyüan · $1.2M – $50M

How we know: the company's own site · Not right? Tell us

Presence Capital✓ confirmed by ProprioSan Francisco · $25K – $100K

How we know: the company's own site · Not right? Tell us

BOLD Longevitylisted by BOLD LongevityBoston

Recode Ventureslisted by Recode VenturesSan Franciscovia Armen A. Vidian · inferred

How we know: Recode Ventures's portfolio page · Not right? Tell us

SquareOne Capitallisted by SquareOne CapitalMiami

The Venture Reality Fundlisted by The Venture Reality FundRedwood City · $100K – $500K

How we know: The Venture Reality Fund's portfolio page · Not right? Tell us

Trousdale Ventureslisted by Trousdale VenturesWest Hollywood · $1M – $5M

Funding

SEC filings, press & company announcements

$43M disclosed across 1 of 4 rounds · 2020–2023

$43MSeries BJul 2023 · 3 sources
Source ↗
Undisclosed amountSeries AJun 2020
DCVC (Data Collective) (lead), BOLD Capital Partners, Cota Capital
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 2

by search overlap

Intuitive9 shared keywordsIntuitive develops robotic-assisted surgical systems, including the da Vinci systems for minimally invasive surgery and the Ion system for bronchoscopy. Its products are medical devices used by surgeons and physicians in healthcare settings.

Cqmedical7 shared keywordsCQ Medical develops patient positioning and immobilization products used in radiation therapy, including devices for brachytherapy, SBRT, SRS, and proton treatments. Its offerings serve oncology and radiotherapy clinicians treating cancer and conditions such as osteoarthritis.

Companies competing with Proprio for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Proprio do?: Proprio develops Paradigm, an implant-agnostic surgical platform that provides intraoperative guidance and structured surgical data without requiring 3D imaging or mobile CT. The system is built for hospitals and health systems to increase surgical capacity, standardize performance, and support clinical training through an AI foundation model trained on data from hundreds of surgeons.
Who founded Proprio?: Proprio was founded by Gabriel Jones, Samuel Browd, Joshua Smith, James Youngquist in 2016.
Who are Proprio's investors?: Proprio's investors include Bold Capital Partners, Cota Capital, DCVC (Data Collective), Bird B. AG, HTC, Presence Capital, BOLD Longevity, Recode Ventures and 3 more.
How much funding has Proprio raised?: Proprio has disclosed $43M raised across 1 of its 4 known rounds.
Where is Proprio headquartered?: Proprio is headquartered in Seattle, US.